Drug Type Small molecule drug |
Synonyms ML248 |
Target |
Action agonists |
Mechanism EDG6 agonists(Sphingosine 1-phosphate receptor Edg-6 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | United States | 01 Jan 2010 |